139 related articles for article (PubMed ID: 2997179)
1. Effect of 1,25-dihydroxyvitamin D3 on phospholipid metabolism in a clonal osteoblast-like rat osteogenic sarcoma cell line.
Matsumoto T; Kawanobe Y; Morita K; Ogata E
J Biol Chem; 1985 Nov; 260(25):13704-9. PubMed ID: 2997179
[TBL] [Abstract][Full Text] [Related]
2. Effect of 1,25-dihydroxyvitamin D3 on phospholipid metabolism in cultured bovine parathyroid cells.
Sugimoto T; Ritter C; Slatopolsky E; Morrissey J
Endocrinology; 1988 Jun; 122(6):2387-92. PubMed ID: 3131114
[TBL] [Abstract][Full Text] [Related]
3. Action of 1,25-dihydroxyvitamin D3 on phospholipid metabolism of human bone cells in culture.
Haining SA; Galloway JH; Brown BL; Guilland-Cumming DF
J Endocrinol; 1988 Mar; 116(3):435-41. PubMed ID: 3127522
[TBL] [Abstract][Full Text] [Related]
4. Effect of parathyroid hormone on phospholipid metabolism in osteoblast-like rat osteogenic sarcoma cells.
Matsumoto T; Morita K; Kawanobe Y; Ogata E
Biochem J; 1986 Jun; 236(2):605-8. PubMed ID: 3019320
[TBL] [Abstract][Full Text] [Related]
5. The activity of 22-oxacalcitriol in osteoblast-like (ROS 17/2.8) cells.
Pernalete N; Mori T; Nishii Y; Slatopolsky E; Brown AJ
Endocrinology; 1991 Aug; 129(2):778-84. PubMed ID: 1649745
[TBL] [Abstract][Full Text] [Related]
6. Phenotype-associated changes in the effects of 1,25-dihydroxyvitamin D3 on alkaline phosphatase and bone GLA-protein of rat osteoblastic cells.
Spiess YH; Price PA; Deftos JL; Manolagas SC
Endocrinology; 1986 Apr; 118(4):1340-6. PubMed ID: 3485045
[TBL] [Abstract][Full Text] [Related]
7. 1,25-Dihydroxyvitamin D3 inhibits synthesis and enhances degradation of proteoglycans in osteoblastic cells.
Takeuchi Y; Matsumoto T; Ogata E; Shishiba Y
J Biol Chem; 1989 Nov; 264(31):18407-13. PubMed ID: 2808381
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of action of 1,25-dihydroxyvitamin D3-induced stimulation of alkaline phosphatase in cultured osteoblast-like cells.
Manolagas SC; Spiess YH; Burton DW; Deftos LJ
Mol Cell Endocrinol; 1983 Nov; 33(1):27-36. PubMed ID: 6357897
[TBL] [Abstract][Full Text] [Related]
9. 1,25-Dihydroxyvitamin D3 inhibits Na(+)-dependent phosphate transport in osteoblastic cells.
Green J; Luong KV; Kleeman CR; Ye LH; Chaimovitz C
Am J Physiol; 1993 Feb; 264(2 Pt 1):C287-95. PubMed ID: 8447362
[TBL] [Abstract][Full Text] [Related]
10. 1,25-Dihydroxyvitamin D3 or dexamethasone modulate arachidonic acid uptake and distribution into glycerophospholipids by normal adult human osteoblast-like cells.
Cissel DS; Birkle DL; Whipkey DL; Blaha JD; Graeber GM; Keeting PE
J Cell Biochem; 1995 Apr; 57(4):599-609. PubMed ID: 7615644
[TBL] [Abstract][Full Text] [Related]
11. Stimulation by 1,25-dihydroxyvitamin D3 of in vitro mineralization induced by osteoblast-like MC3T3-E1 cells.
Matsumoto T; Igarashi C; Takeuchi Y; Harada S; Kikuchi T; Yamato H; Ogata E
Bone; 1991; 12(1):27-32. PubMed ID: 2054233
[TBL] [Abstract][Full Text] [Related]
12. 1 alpha,25-Dihydroxyvitamin D3 rapidly alters phospholipid metabolism in the nuclear envelope of osteoblasts.
Sorensen AM; Baran DT
J Cell Biochem; 1995 May; 58(1):15-21. PubMed ID: 7642719
[TBL] [Abstract][Full Text] [Related]
13. Dexamethasone enhances vitamin D-24-hydroxylase expression in osteoblastic (UMR-106) and renal (LLC-PK1) cells treated with 1alpha,25-dihydroxyvitamin D3.
Kurahashi I; Matsunuma A; Kawane T; Abe M; Horiuchi N
Endocrine; 2002 Mar; 17(2):109-18. PubMed ID: 12041912
[TBL] [Abstract][Full Text] [Related]
14. The effects of 1,25-dihydroxyvitamin D3 and dexamethasone on rat osteoblast-like primary cell cultures: receptor occupancy and functional expression patterns for three different bioresponses.
Chen TL; Hauschka PV; Cabrales S; Feldman D
Endocrinology; 1986 Jan; 118(1):250-9. PubMed ID: 3000737
[TBL] [Abstract][Full Text] [Related]
15. 1,25-Dihydroxyvitamin D3 differentially regulates the production of insulin-like growth factor I (IGF-I) and IGF-binding protein-4 in mouse osteoblasts.
Scharla SH; Strong DD; Mohan S; Baylink DJ; Linkhart TA
Endocrinology; 1991 Dec; 129(6):3139-46. PubMed ID: 1720089
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of 1,25-dihydroxyvitamin D3-analogs on osteoblast-like cells and on in vitro bone resorption.
van den Bemd GJ; Pols HA; Birkenhäger JC; Kleinekoort WM; van Leeuwen JP
J Steroid Biochem Mol Biol; 1995 Dec; 55(3-4):337-46. PubMed ID: 8541230
[TBL] [Abstract][Full Text] [Related]
17. Dexamethasone increases 1,25-dihydroxyvitamin D3 receptor levels and augments bioresponses in rat osteoblast-like cells.
Chen TL; Hauschka PV; Feldman D
Endocrinology; 1986 Mar; 118(3):1119-26. PubMed ID: 3004896
[TBL] [Abstract][Full Text] [Related]
18. The effect of 1,25-dihydroxyvitamin D3 on the cytoskeleton of rat calvaria and rat osteosarcoma (ROS 17/2.8) osteoblastic cells.
Gronowicz G; Egan JJ; Rodan GA
J Bone Miner Res; 1986 Oct; 1(5):441-55. PubMed ID: 3332554
[TBL] [Abstract][Full Text] [Related]
19. A highly potent 26,27-Hexafluoro-1a,25-dihydroxyvitamin D3 on calcification in SV40-transformed human fetal osteoblastic cells.
Miyahara T; Simoura T; Osahune N; Uchida Y; Sakuma T; Nemoto N; Kozakai A; Takamura T; Yamazaki R; Higuchi S; Chiba H; Iba K; Sawada N
Calcif Tissue Int; 2002 Jun; 70(6):488-95. PubMed ID: 12016462
[TBL] [Abstract][Full Text] [Related]
20. 1,25-Dihydroxyvitamin D3 stimulates the alkaline phosphatase activity of osteoblast-like cells.
Manolagas SC; Burton DW; Deftos LJ
J Biol Chem; 1981 Jul; 256(14):7115-7. PubMed ID: 6941964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
